Search for content, post, videos

Investor supports Agnafit Bidco’s bid for Sobi

Guido Oelkers
Investor AB has undertaken to accept the public offer made September 2, by Agnafit Bidco for the shares in Swedish Orphan Biovitrum at a price per share of SEK 235. Investor owns 107.6 million shares in Sobi, representing 35.4 percent of the capital and votes. The offer values Investor’s shares
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.